Sarepta Therapeutics, Inc.
SRPT
26 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 14 12:03 AM | Stephen MayoDirector | Sale | 7,239 | $17.02 | $123.2K | 1,765(D) | View → |
| Mar 12, 2026 | Mar 12 8:27 PM | STEPHEN MAYO | Proposed Sale | 7,239 | $17.02 | $123.2K | — | View → |
| Dec 16, 2025 | Dec 16 10:05 PM | IAN M ESTEPAN | Proposed Sale | 13,187 | $22.31 | $294.1K | — | View → |
| Mar 12, 2025 | Mar 12 9:33 PM | Nicaise Claude | Proposed Sale | 2,491 | $99.65 | $248.2K | — | View → |
| Dec 12, 2024 | Dec 12 10:06 PM | Wigzell Hans Lennart Rudolf | Proposed Sale | 10,500 | $124.80 | $1.3M | — | View → |
| Dec 5, 2024 | Dec 5 9:18 PM | Boor Kathryn Jean | Proposed Sale | 1,636 | $125.55 | $205.4K | — | View → |
| Aug 30, 2024 | Aug 30 9:03 PM | Estepan Ian Michael | Proposed Sale | 5,985 | $137.37 | $822.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | Mar 4 1:04 AM | Ian Michael EstepanChief Operating Officer | Option Exercise | 8,125 | — | 0(D) | View → |
| Mar 1, 2026 | Mar 4 1:02 AM | Louise Rodino-KlapacPresident, R&D and Tech Ops | Option Exercise | 8,125 | — | 0(D) | View → |
| Feb 26, 2026 | Mar 2 1:00 PM | Ian Michael EstepanChief Operating Officer | Option Exercise | 7,450 | $13.71 | 0(D) | View → |
| Feb 25, 2026 | Feb 28 1:05 AM | Ian Michael EstepanChief Operating Officer | Grant/Award | 1,875 | — | 8,125(D) | View → |
| Feb 25, 2026 | Feb 28 1:03 AM | Louise Rodino-KlapacPresident, R&D and Tech Ops | Grant/Award | 1,875 | — | 8,125(D) | View → |
| Jan 29, 2026 | Jan 30 1:05 AM | Claude NicaiseDirector | Option Exercise | 10,500 | $13.71 | 0(D) | View → |
| Jan 27, 2026 | Jan 30 1:04 AM | Kathleen M BehrensDirector | Option Exercise | 10,500 | $13.71 | 0(D) | View → |